1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Overlaps and divergences between tauopathies and synucleinopathies : a duet of neurodegeneration
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Novel data-driven subtypes and stages of brain atrophy in the ALS–FTD spectrum
(
- Contribution to journal › Article
-
Mark
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
(
- Contribution to journal › Article
- 2022
-
Mark
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
(
- Contribution to journal › Article
-
Mark
Why do ‘OFF’ periods still occur during continuous drug delivery in Parkinson’s disease?
(
- Contribution to journal › Scientific review
- 2021
-
Mark
Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
(
- Contribution to journal › Article
- 2019
-
Mark
Dihydromyricetin and Salvianolic acid B inhibit alpha-synuclein aggregation and enhance chaperone-mediated autophagy
(
- Contribution to journal › Article
-
Mark
Microbiome changes : an indicator of Parkinson's disease?
(
- Contribution to journal › Scientific review
- 2018
-
Mark
Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease
(
- Contribution to journal › Article